Subscribe: Lymphoma / Leukemia / Myeloma News From Medical News Today
Added By: Feedage Forager Feedage Grade A rated
Language: English
acute  blood  bone marrow  cancer  cell  cells  leukaemia  leukemia  lymphoma  new  patients  researchers  shows promise  treatment 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Lymphoma / Leukemia / Myeloma News From Medical News Today

Lymphoma / Leukemia / Myeloma News From Medical News Today

Leukemia is a cancer of the blood cells, usually affecting the white blood cells, which causes these cells to not work properly. There are four main types of leukemia. Lymphoma is a type of cancer that originates in the lymphatic system. There are two mai

Copyright: Copyright 2016 Medical News Today

Genetic hallmarks of acute lymphoblastic leukemia subtype uncovered

Tue, 25 Oct 2016 00:00:00 PDT

St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project team identifies genetic changes underlying a type of B-precursor acute lymphoblastic leukemiaAn...

New drug combination shows promise in tackling leukaemia treatment resistance

Tue, 18 Oct 2016 06:00:00 PDT

Early testing of a new drug combination that attacks the most common form of leukaemia on multiple fronts has shown great promise in targeting cancer cells.

Low cost method for examining single leukemia cells could transform treatment

Tue, 18 Oct 2016 00:00:00 PDT

Leukemia is a disease in which each cell can exhibit different genetic traits, and now Swedish researchers have found a cheap way to examine the individual cells.

Leukaemia cell movement gives clues to tackling treatment-resistant disease

Tue, 18 Oct 2016 00:00:00 PDT

New research is shedding light on how leukaemia cells can survive cancer treatment, suggesting new possibilities for stopping them in their tracks.

New treatment approach for leukemia renders cancer genes powerless

Fri, 14 Oct 2016 00:00:00 PDT

In leukemia cells it is often the case that genes are reactivated that, in physiological terms, mediate the self-renewal of blood stem cells.

Vitamins A and C help erase cell memory

Thu, 13 Oct 2016 05:00:00 PDT

Vitamins A and C aren't just good for your health, they affect your DNA too.

Epigenetics provides new insights into the pathogenesis of lymphoma

Fri, 07 Oct 2016 00:00:00 PDT

Cancer cells have a different DNA methylation pattern from that of healthy cells.

New immunotherapy for leukemia shows promise in small clinical trial

Mon, 03 Oct 2016 05:00:00 PDT

A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place.

Brain cancer and leukemia: New molecular mechanisms decoded

Fri, 16 Sep 2016 00:00:00 PDT

A joint research published in Nature Communications has shown new molecular causes of brain cancer and leukemia.

Many adolescent girls with leukemia are not being screened for pregnancy before beginning chemotherapy

Tue, 13 Sep 2016 00:00:00 PDT

A new study indicates that adolescent females with acute leukemia have low rates of pregnancy screening prior to receiving chemotherapy that can cause birth defects.

Important signalling pathway for leukaemia cells discovered - Enables development of new treatments

Fri, 02 Sep 2016 05:00:00 PDT

Acute lymphoblastic leukaemia (T-ALL) is an aggressive form of blood cancer.

Barcodes show the blood family tree

Mon, 29 Aug 2016 00:00:00 PDT

By assigning a barcode to stem cells, researchers at Lund University in Sweden have made it possible to monitor large blood cell populations as well as individual blood cells, and study the changes...

Breakthrough in cancer cell screening advances personalised treatment of childhood leukaemia

Fri, 19 Aug 2016 00:00:00 PDT

Researchers at Newcastle University have been able to accurately predict how children whose cancer returns after treatment for leukaemia are likely to respond to further treatment.

Leukaemia blood testing has 'massive potential'

Thu, 18 Aug 2016 00:00:00 PDT

Researchers at The University of Manchester have unlocked the potential of a new test which could revolutionise the way doctors diagnose and monitor a common childhood leukaemia.

Researchers develop new strategy to limit side effects of stem cell transplants

Tue, 16 Aug 2016 09:00:00 PDT

Scientists in Germany have developed a new approach that may prevent leukemia and lymphoma patients from developing graft-versus-host disease (GvHD) after therapeutic bone marrow transplants.

Venetoclax safe, shows promise in patients with acute myelogenous leukemia

Tue, 16 Aug 2016 00:00:00 PDT

Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2...

Research reveals insights into genetics behind common blood cancer

Mon, 15 Aug 2016 05:00:00 PDT

Scientists at The Institute of Cancer Research, London, have identified how an inherited genetic variant, associated with an increased risk of developing the most common type of leukaemia, helps...

New drug class gives hope for better treatments for incurable myeloma

Wed, 10 Aug 2016 00:00:00 PDT

Australian researchers have discovered that a new class of anti-cancer agents may be effective in treating multiple myeloma, an incurable bone marrow cancer.

Blocking the migration of cancer cells to destroy them

Mon, 08 Aug 2016 05:00:00 PDT

Lymphoma is a cancer that affects lymphocytes, a type of white blood cell. The disease originates in a lymphoid organ (lymph node, spleen, or bone marrow) before spreading through the blood to...

Leukaemia study takes aim at therapy resistant proteins

Mon, 01 Aug 2016 00:00:00 PDT

Assessing a patient's levels of the P-glycoprotein soon after they start receiving Glivec therapy will help to predict that patient's long-term response to the leukaemia drug, according to new...

Cord blood outperforms matched, unrelated donor in bone marrow transplant

Thu, 28 Jul 2016 02:00:00 PDT

A University of Colorado Cancer Center study compared outcomes of leukemia patients receiving bone marrow transplants from 2009-2014, finding that three years post transplant, the incidence of...

Blood disorders cost €23 billion to European economy

Fri, 22 Jul 2016 00:00:00 PDT

Healthcare costs per patient with blood cancers are two times higher than average cancer costs, due to long hospital stays and complex treatment and diagnosis.

Five-year survival data suggest brentuximab vedotin potentially curative in some hodgkin lymphoma patients with limited treatment options

Tue, 19 Jul 2016 05:00:00 PDT

Phase II trial suggests therapy should be standard of care for patients facing relapsed or treatment-resistant Hodgkin lymphoma.

REVLIMID (lenalidomide) approved by the European Commission for the treatment of relapsed/refractory patients with mantle cell lymphoma

Mon, 18 Jul 2016 09:00:00 PDT

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation has announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) for the treatment of adult...

Researchers find open chromatin profiling key to identifying leukemia cells of origin

Tue, 12 Jul 2016 07:00:00 PDT

Every cancer starts with a single cell, and Jackson Laboratory (JAX) researchers have found a precise and reliable way - whole-genome profiling of open chromatin - to identify the kind of cell that...